Tenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing - TENX News | RalliesTenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing
T
TENX• ADAR1 Capital Management reported as 10% owner
- Tenax Therapeutics Form 3 disclosed ADAR1 Capital Management as a 10% owner, reporting 3,827,951 shares of common stock.
- Holdings also included 59,073 pre-funded warrants exercisable at USD 0.01 per share.
- Filing listed 31,096 warrants exercisable at USD 4.5 per share.
- Ownership event date was Aug. 20, 2026; the filing was signed Aug. 24, 2026.
•
